Performance funds/ETFs
iShares | iShares Healthcare Innovation ETF Acc
The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Funds assets, which reflects the return of the STOXX Global Breakthrough Healthcare Index. The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index.
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€7,60
Quote date
01-04-2026
Performance in EUR
Date
31-03-2026
This year
-2,39%
1 week
1,93%
1 month
-4,58%
3 months
-2,39%
6 months
7,17%
1 year
9,91%
3 years (annualised)
3,49%
5 years (annualised)
-2,05%
Since start (annualised)
5,53%
Indicators
Standard deviation (3yr)
16,00%
Share ratio (3yr)
0,12
Beta (3yr)
1,02
Alpha (3yr)
0,62
Tracking error (3yr)
-
Top 10 holdings (30-03-2026)
Johnson & Johnson
2,45 %
UCB SA
2,44 %
Moderna Inc
2,39 %
Merck & Co Inc
2,29 %
Biogen Inc
2,19 %
Illumina Inc
2,17 %
GSK PLC
2,11 %
Novartis AG Registered Shares
1,99 %
Gilead Sciences Inc
1,96 %
Bristol-Myers Squibb Co
1,89 %
Fees
Entry fee
-->Tarievenkaart / Cost information sheet
Exit charges
-->Tarievenkaart / Cost information sheet
Estimated ongoing charges
0,40%
Dividend
Dividend paying
No
Characteristic
Asset Manager
iShares
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Passive
Fund code
60081
Fund code fractional orders
-
Fund manager name
Not available
ISIN
IE00BYZK4776
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Ireland
Currency
EUR
Fund size (mio)
$860,93 (01-04-2026)
Cut-off time
-
Execution date
niet van toepassing: directe verhandeling op de beurs
Inception date
08-09-2016
Benchmark
STOXX Global Breakthrough Healthcare
Minimum investment amount
-
Assortiment
Self Directed Investing Basic, Self Directed Investing Plus, Investment advice